Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07806565) titled 'Naloxone for In-Hospital Cardiac Arrest' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Region Skane
Condition:
Heart Arrest
Intervention:
Drug: naloxone
Recruitment Status: Not recruiting
Phase: Phase 2/Phase 3
Date of First Enrollment: January 1, 2027
Target Sample Size: 850
To know more, visit https://clinicaltrials.gov/study/NCT07806565
Disclaimer: Curated by HT Syndication....